Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
AIDS (London, England)|July 4, 2006
Abacavir hypersensitivity reaction in primary HIV infectionJoanne Stekler, Janine Maenza, Claire Stevens, et al.Journal of Virology|March 3, 2007
Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infectionUma Malhotra, Fusheng Li, Jessica Nolin, et al.Journal of Clinical Medicine|April 30, 2021
Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19Alyssa Ylescupidez, Aaron Rips, Henry T Bahnson, et al.Open Forum Infectious Diseases|March 31, 2025
Limitations of the MTB/RIF Assay: An Xpert Review of 4 Clinical CasesAllison L Haas, Angela Ma, Jonathan Pham, et al.Vaccine|August 8, 2006
Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluationFusheng Li, Uma Malhotra, Peter B Gilbert, et al.Journal of Virology|January 29, 2003
Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infectionUma Malhotra, Sarah Holte, Tuofu Zhu, et al.Plos Pathogens|December 29, 2021
Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individualsAlexandra M Johansson, Uma Malhotra, Yeseul G Kim, et al.Human Vaccines|April 3, 2008
Towards prediction of degenerate CTL epitope recognitionFusheng Li, Denise M McKenney, Uma Malhotra, et al.The Journal of Clinical Investigation|February 2, 2021
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severityHamid Bolouri, Cate Speake, David Skibinski, et al.The Journal of Infectious Diseases|February 21, 2004
HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentationPeter C Chien, Daniel Chen, Pei-De Chen, et al.Pageof 3